Cargando…

Perioperative immunotherapy for esophageal squamous cell carcinoma: Now and future

Esophageal cancer (EC) ranks among the most prevalent malignant tumors affecting the digestive tract. Esophageal squamous cell carcinoma (ESCC) stands as the prevailing pathological subtype, encompassing approximately 90% of all EC patients. In clinical stage II-IVA locally advanced ESCC cases, the...

Descripción completa

Detalles Bibliográficos
Autor principal:	Liu, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518742/ https://www.ncbi.nlm.nih.gov/pubmed/37753366 http://dx.doi.org/10.3748/wjg.v29.i34.5020

Ejemplares similares

Immunotherapy in Renal Cell Carcinoma: The Future Is Now
por: Deleuze, Antoine, et al.
Publicado: (2020)

Immunotherapy for Esophageal Squamous Cell Carcinoma
por: Kojima, Takashi, et al.
Publicado: (2017)

Perioperative Outcomes of Minimally Invasive Esophagectomy After Neoadjuvant Immunotherapy for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
por: Cheng, Jiahan, et al.
Publicado: (2022)

Recent Advances in Combination of Immunotherapy and Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
por: Wang, Ruixi, et al.
Publicado: (2022)

Immunotherapies and Future Combination Strategies for Head and Neck Squamous Cell Carcinoma
por: Cristina, Valerie, et al.
Publicado: (2019)

Immunotherapy for Squamous Esophageal Cancer: A Review
por: Petrillo, Angelica, et al.
Publicado: (2022)

Role of perioperative immunotherapy in localized renal cell carcinoma
por: Kaur, Jasmeet, et al.
Publicado: (2023)

Immunotherapy with Checkpoint Inhibitors for Hepatocellular Carcinoma: Where Are We Now?
por: Tovoli, Francesco, et al.
Publicado: (2020)

PET Imaging Biomarkers of Anti-EGFR Immunotherapy in Esophageal Squamous Cell Carcinoma Models
por: Lee, Tae Sup, et al.
Publicado: (2018)

Comparison of neoadjuvant nab‐paclitaxel plus immunotherapy versus paclitaxel plus immunotherapy for esophageal squamous cell carcinoma
por: Yang, Yafan, et al.
Publicado: (2023)

Chemoimmunotherapy in advanced esophageal squamous cell carcinoma: optimizing chemotherapy regimens for immunotherapy combinations
por: Liu, Zhichao, et al.
Publicado: (2022)

Artificial intelligence-assisted esophageal cancer management: Now and future
por: Zhang, Yu-Hang, et al.
Publicado: (2020)

Neoadjuvant immunotherapy for resectable esophagal squamous cell carcinoma: An ace up the sleeve
por: Zhou, Qing, et al.
Publicado: (2023)

Proteoglycans and their functions in esophageal squamous cell carcinoma
por: Zhu, Yun, et al.
Publicado: (2021)

Cutaneous Squamous Cell Carcinoma in the Age of Immunotherapy
por: Ishitsuka, Yosuke, et al.
Publicado: (2021)

Safety and Feasibility of Esophagectomy Following Neoadjuvant Immunotherapy Combined with Chemotherapy for Esophageal Squamous Cell Carcinoma
por: Gu, Yi-Min, et al.
Publicado: (2022)

Perioperative outcomes of neoadjuvant immunotherapy plus chemotherapy and neoadjuvant chemoradiotherapy in the treatment of locally advanced esophageal squamous cell carcinoma: a retrospective comparative cohort study
por: Zhang, Hai, et al.
Publicado: (2023)

Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: The Current and Future Role of Radiation Therapy in the Era of Immunotherapy
por: Ferini, Gianluca, et al.
Publicado: (2022)

Chimeric Antigen Receptor T-Cells: The Future Is Now
por: Mchayleh, Wassim, et al.
Publicado: (2019)

Immunotherapy and Hepatocellular Cancer: Where Are We Now?
por: Valery, Marine, et al.
Publicado: (2022)

Clinical and prognostic significance of perioperative change in red cell distribution width in patients with esophageal squamous cell carcinoma
por: Zhang, Peng, et al.
Publicado: (2023)

Immunotherapy for head and neck squamous cell carcinoma
por: Fuereder, Thorsten
Publicado: (2016)

Efficacy and safety of neoadjuvant chemotherapy and immunotherapy in locally resectable advanced esophageal squamous cell carcinoma
por: Wu, Zhigang, et al.
Publicado: (2021)

How we treat esophageal squamous cell carcinoma
por: Puhr, H.C., et al.
Publicado: (2023)

The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches
por: Economopoulou, Panagiota, et al.
Publicado: (2017)

Immunotherapy and Systemic Treatment of Cutaneous Squamous Cell Carcinoma
por: Aboul-Fettouh, Nader, et al.
Publicado: (2021)

Electroacoustic Stimulation: Now and into the Future
por: Irving, S., et al.
Publicado: (2014)

Radiotherapy, Chemotherapy and Immunotherapy—Current Practice and Future Perspectives for Recurrent/Metastatic Oral Cavity Squamous Cell Carcinoma
por: Melo-Alvim, Cecília, et al.
Publicado: (2022)

Case Report: First-Line Immunotherapy for Esophageal Squamous Carcinoma Combined With Hypopharyngeal Squamous Carcinoma Yields Sustained Survival Benefit
por: Yang, Yi, et al.
Publicado: (2022)

Adjuvant Therapy for Esophageal Squamous Cell Carcinoma
por: Sun, Jong-Mu
Publicado: (2020)

The Future Is Now
por: Tilson, Hugh A., et al.
Publicado: (2012)

The future is now
por: Fernandes, Frederico Leon Arrabal, et al.
Publicado: (2019)

Adjuvant immunotherapy in resected esophageal squamous cell carcinoma: a gospel to the non-pCRs
por: Zhang, Zhihui, et al.
Publicado: (2021)

Immunotherapy Mechanism of Esophageal Squamous Cell Carcinoma with the Effect of STK11/AMPK Signaling Pathway
por: Xia, Yang, et al.
Publicado: (2022)

Prognostic Value of Lactate Dehydrogenase in Second-Line Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma
por: Li, Yan, et al.
Publicado: (2022)

Liquid electron microscopy: then, now and future
por: Bharda, Anahita Vispi, et al.
Publicado: (2019)

Oral Immunotherapy in Food Allergy: Where Are We Now?
por: Özdemir, Pınar Gökmirza, et al.
Publicado: (2023)

Peptide-based immunotherapy in lupus: Where are we now?
por: P. Singh, Ram, et al.
Publicado: (2023)

Neck Dissection for Thoracic Esophageal Squamous Cell Carcinoma
por: Yajima, Satoshi, et al.
Publicado: (2012)

Precision screening for esophageal squamous cell carcinoma in China
por: He, Zhonghu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v7ure2ii79jd3srodm5pc5ihsu